Expecting Green light from health Canada this week with FDA submission. NSP will rock on those news. Company is getting ready for clinical trial 2. It shows confidence to get Health Canada approval.
due to circumstances created by the COVID-19 pandemic measures, the Company will be delaying the filing of its annual financial statements and related management discussion and analysis for the year ended December 31, 2019 until a date that is on or before June 15, 2020.
> Pretty common for a lot of companies to delay under the COVID-19 situation as I stated on May 7th IMO the delay of the financials is only due to circumstances created by the COVID-19 pandemic; if you happen to follow the Stockwatch daily news feed you will have seen tons of companies notifying the delay of their financial statements.
- Not immediatly filling a PP at half the price of the current stock price which held for over a week. (Is the PP still open?)
> I doubt the PP will be open much longer, probably close soon! I’m not waiting I'm in :<)
- Is there a reason why investors are not wanting to hold this half-priced deal with amazing warrants for 4 months from pp closing?
> Given the times we are living in a lot of people want flexibility and the 4 month hold is likely a deterrent for some.
- Feel free to add why a investor should buy before seeing 2019 year end
> You can wait until they are released (before June 15th) but you are waiting 5 ½ months putting a lot of emphasis on waiting for past history when NSP is moving forward. I made my 2019 prediction on January 4th proving links to charts, etc. supporting my guess. Even if my $3.1 million guess turns out to only be $2.9 million – it’s a good year over year improvement.
> Based on the news releases etc. during the quarter, Q1Y20 was heading to be an exceptional quarter and the results may still be great. Q2Y20 will likely be tempered due to the COVID-19 situation but as I stated on May 7th - lots going on that we just haven’t been told about yet ;<)
